Oligometastatic ACC, generally characterized by limited metastatic burden and an indolent biological behavior, such as stage IVa and Ki-67 lower than 20%, may represent a distinct clinical subset where aggressive multimodal strategies can lead to meaningful disease control and prolonged survival. Here, MKI67 is linked to adrenal cortex carcinoma.